Cabergoline monotherapy in the long-term treatment of Cushing's disease

Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease

(2010) Richard A. Feelders et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of injectable bromocriptine in patients with Cushing's disease

(2009) C. Invitti et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas

(2009) Christiaan de Bruin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing’s disease

(2009) Lucio Vilar et al.   Pituitary

Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing’s Disease

(2008) C. de Bruin et al.   ENDOCRINOLOGY

Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

(2008) B. M. K. Biller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

(2008) M. Boscaro et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery

(2008) Rosario Pivonello et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM